Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. (Q30369679)

21 June 2017

title

Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. (English)

1 reference

21 June 2017

0 references

Richard J Webby

1 reference

21 June 2017

Peggy A Lalor

1 reference

21 June 2017

Jane Morrow

1 reference

21 June 2017

Denis Rusalov

1 reference

21 June 2017

David C Kaslow

1 reference

21 June 2017

Alain Rolland

1 reference

21 June 2017

Larry R Smith

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Journal of Infectious Diseases

21 June 2017

published in

1 reference

21 June 2017

volume

197

1 reference

21 June 2017

1 reference

21 June 2017

page(s)

1643-1652

1 reference

21 June 2017

cites work

A history of influenza

1 reference

Avian influenza virus (H5N1): a threat to human health.

21 January 2018

1 reference

Seasonal and pandemic influenza preparedness: science and countermeasures

21 January 2018

1 reference

Three Indonesian clusters of H5N1 virus infection in 2005

21 January 2018

1 reference

Vaccines for seasonal and pandemic influenza.

21 January 2018

1 reference

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

21 January 2018

1 reference

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

21 January 2018

1 reference

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

21 January 2018

1 reference

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

21 January 2018

1 reference

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

21 January 2018

1 reference

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

21 January 2018

1 reference

The annual production cycle for influenza vaccine

21 January 2018

1 reference

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

DNA Immunization for Influenza Virus: Studies Using Hemagglutinin‐ and Nucleoprotein‐Expressing DNAs

21 January 2018

1 reference

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

21 January 2018

1 reference

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

21 January 2018

1 reference

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine

21 January 2018

1 reference

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

21 January 2018

1 reference

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

21 January 2018

1 reference

Characterization of the 1918 influenza virus polymerase genes

21 January 2018

1 reference

The origins of pandemic influenza--lessons from the 1918 virus.

21 January 2018

1 reference

Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

21 January 2018

1 reference

Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines

21 January 2018

1 reference

Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.

21 January 2018

1 reference

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

21 January 2018

1 reference

Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets

21 January 2018

1 reference

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/588431

1 reference

21 June 2017

1 reference